Advertisement

Topics

Alzheimer's Drug Discovery Foundation Company Profile

06:27 EDT 19th March 2019 | BioPortfolio

The ADDF is the only public charity whose sole mission is to accelerate the discovery and development of drugs to prevent, treat and cure Alzheimer's disease, related dementias and cognitive aging. Since 1998, the ADDF has granted more than $40 million to fund over 295 Alzheimer's drug discovery programs in academic centers and biotechnology companies in 15 countries.


News Articles [3731 Associated News Articles listed on BioPortfolio]

Mediaplanet Partners Up with the Alzheimer’s Drug Discovery Foundation, Allergan, Bryan Cranston, Joan Lunden and Others to Help Raise Awareness for Alzheimer’s

NEW YORK (PRWEB) November 23, 2018 Today, Mediaplanet announces the launch of this November’s edition of “Alzheimer’s...

New generation of therapeutics based on understanding of aging biology show promise for Alzheimer's disease

(Alzheimer's Drug Discovery Foundation) A scientific strategy that explores therapeutic targets based on the biology of aging is gaining ground as an effective approach to prevent and treat Alzheimer'...

Lilly And AC Immune Partner On A Small Molecule With Potential In Alzheimer's Combinations

Eli Lilly signed a licensing deal to develop a tau aggregation inhibitor small molecule for Alzheimer's disease – a drug...  

Cure for Alzheimer’s could be just six years away, scientists say – iNews

iNewsCure for Alzheimer's could be just six years away, scientists sayiNewsScientists believe they are on the brink of finding a cure for Alzheimer's disease after coming up with a new way to tackle i...

Discovery could explain failed clinical trials for Alzheimer's, and provide a solution

Researchers at King's College London have discovered a vicious feedback loop underlying brain degeneration in Alzheimer's disease which may explain why so many drug trials have failed. The study also ...

First Alzheimer's drug from Eisai/UCL alliance to enter clinical trials

The first drug candidate from Eisai and University College London (UCL)’s drug discovery collaboration is to enter Phase I clinical trials for Alzheimer’s disease (AD) early next year.

How An Alzheimer Treatment's Success Highlights The Failures In Alzheimer's Drug Research

How the takeover of a biotech company with a late stage Alzheimer's Drug highlights the lack of any other success in the fight against Alzheimer's. And how we must look at new ways to advance research...

Tetra Inks Deal with Shionogi to Support Fragile X, Alzheimer’s R&D

The lead drug of Tetra Discovery Partners is already in mid-stage clinical studies as a treatment for the rare Fragile X Syndrome. But the Grand Rapids, MI, biotech says its drug could also treat a di...

Drugs and Medications [172 Associated Drugs and Medications listed on BioPortfolio]

Rivastigmine [amneal pharmaceuticals llc]

These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM.   RIVAS...

Donepezil hydrochloride [kaiser foundation hospitals]

These highlights do not include all the information needed to use donepezil hydrochloride tablets, USP safely and effectively. See full prescribing information for donepezil hydrochloride tablets, USP...

Rivastigmine tartrate [sandoz inc]

These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules. Rivastigmi...

Rivastigmine tartrate [alembic pharmaceuticals limited]

These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules USP safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules USP. Ri...

Donepezil hydrochloride [dr. reddys laboratories limited]

These highlights do not include all the information needed to use DONEPEZIL HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for DONEPEZIL HYDROCHLORIDE TABLETS. DONEPEZI...

PubMed Articles [4221 Associated PubMed Articles listed on BioPortfolio]

A systems-based model of Alzheimer's disease.

The new National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease has been developed to accelerate drug discovery and offer a common structure and language...

Progress in Inherited Retinal Disease Drug Discovery and Development: A Foundation's Perspective.

Ophthalmic drug discovery and development has enjoyed a recent renaissance, with a major shift away from reformulating old systemic drugs for ocular use to de novo discovery of drugs for specific ocul...

Induced pluripotent stem cells for neural drug discovery.

Neurological diseases such as Alzheimer's disease and Parkinson's disease are growing problems, as average life expectancy is increasing globally. Drug discovery for neurological disease remains a maj...

Lycorine: A prospective natural lead for anticancer drug discovery.

Nature is the most abundant source for novel drug discovery. Lycorine is a natural alkaloid with immense therapeutic potential. Lycorine is active in a very low concentration and with high specificity...

Meeting the discovery challenge of drug-resistant infections: progress and focusing resources.

Following multiple warnings from governments and health organisations, there has been renewed investment, led by the public sector, in the discovery of novel antimicrobials to meet the challenge of ri...

Clinical Trials [4042 Associated Clinical Trials listed on BioPortfolio]

Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study

ALADDIN is a research study to investigate the safety and effectiveness of leuprolide (a hormone drug) to improve the cognitive function and slow the progression of Alzheimer's disease (AD...

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

The purpose of this study is to evaluate the safety and efficacy of 2 fixed doses of EVP-6124 compared to placebo for 26 weeks in subjects with mild to moderate Alzheimer's disease current...

Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease

This study will perform a targeted metabolic analysis in blood and urine samples from subjects attending the Baylor AT&T Memory Center. The aim is to identify novel biomarkers that can dis...

Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease

The aim of this study is to determine the effectiveness of treatment with raloxifene, an estrogen-like medication approved by the Food and Drug Administration for the treatment of osteopor...

Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease

Alzheimer's disease is a medical illness that damages the brain and causes problems with memory, mood and behavior. A substance called acetylcholine (ACh), which is naturally produced in t...

Companies [4052 Associated Companies listed on BioPortfolio]

Alzheimer's Drug Discovery Foundation (ADDF)

Alzheimer's Drug Discovery Foundation (http://www.alzdiscovery.org/) is the only public charity whose sole mission is to fund drug discovery and development to prevent, treat, and cure Alzheimer's dis...

Alzheimer's Drug Discovery Foundation

The ADDF is the only public charity whose sole mission is to accelerate the discovery and development of drugs to prevent, treat and cure Alzheimer's disease, related dementias and cognitive aging. Si...

The Alzheimer’s Drug Discovery Foundation (ADDF) and the Foundation for Mitochondrial Medicine (FMM)

Alzheimer's Research Foundation

The Fisher Center for Alzheimer's Research Foundation is a leading source of funding for Alzheimer's research. It serves Alzheimer's patients and their families to understand the causes of Alzheimer'...

Alzheimer's Foundation International

The Alzheimer's Foundation International (AFI) is working toward collaboratively setting a paradigm of quality care for individuals with the disease and their families by raising awareness of Alzheime...

More Information about "Alzheimer's Drug Discovery Foundation" on BioPortfolio

We have published hundreds of Alzheimer's Drug Discovery Foundation news stories on BioPortfolio along with dozens of Alzheimer's Drug Discovery Foundation Clinical Trials and PubMed Articles about Alzheimer's Drug Discovery Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alzheimer's Drug Discovery Foundation Companies in our database. You can also find out about relevant Alzheimer's Drug Discovery Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record